BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Clinical Outcome
6 results:

  • 1. Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized clinical Trial.
    Danilenko M; Stamp E; Stocken DD; Husain A; Zangarini M; Cranston A; Stones R; Sinclair N; Hodgson K; Bowett SA; Roblin D; Traversa S; Plummer R; Veal G; Langtry JAA; Ashworth A; Burn J; Rajan N
    JAMA Dermatol; 2018 Aug; 154(8):913-921. PubMed ID: 29955768
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. trka is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines.
    Pasini L; Re A; Tebaldi T; Ricci G; Boi S; Adami V; Barbareschi M; Quattrone A
    BMC Cancer; 2015 Oct; 15():777. PubMed ID: 26496938
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.
    Wiesner T; He J; Yelensky R; Esteve-Puig R; Botton T; Yeh I; Lipson D; Otto G; Brennan K; Murali R; Garrido M; Miller VA; Ross JS; Berger MF; Sparatta A; Palmedo G; Cerroni L; Busam KJ; Kutzner H; Cronin MT; Stephens PJ; Bastian BC
    Nat Commun; 2014; 5():3116. PubMed ID: 24445538
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.
    Jørgensen K; Davidson B; Flørenes VA
    Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. clinical case seminar: in vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinoma.
    D'Aloiso L; Carlomagno F; Bisceglia M; Anaganti S; Ferretti E; Verrienti A; Arturi F; Scarpelli D; Russo D; Santoro M; Filetti S
    J Clin Endocrinol Metab; 2006 Mar; 91(3):754-9. PubMed ID: 16384843
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of activated trka protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.
    Flørenes VA; Maelandsmo GM; Holm R; Reich R; Lazarovici P; Davidson B
    Am J Clin Pathol; 2004 Sep; 122(3):412-20. PubMed ID: 15362372
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.